Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Beyond phase 3 registration trials: defining safety for triple therapy with protease inhibitors in cirrhosisFerenci, P ; Dusheiko, GGut, 2014-07, Vol.63 (7), p.1033-1034 [Periódico revisado por pares]England: BMJ Publishing Group LTDTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Current treatment of hepatitis BDusheiko, G ; Antonakopoulos, NGut, 2008-01, Vol.57 (1), p.105-124 [Periódico revisado por pares]London: BMJ Publishing Group Ltd and British Society of GastroenterologyTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985Yee, T T ; Griffioen, A ; Sabin, C A ; Dusheiko, G ; Lee, C AGut, 2000-12, Vol.47 (6), p.845-851 [Periódico revisado por pares]London: BMJ Publishing Group Ltd and British Society of GastroenterologyTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
HCV infection should be managed in specialist centresDusheiko, GGut, 2002-11, Vol.51 (5), p.625-627 [Periódico revisado por pares]London: BMJ Publishing Group Ltd and British Society of GastroenterologyTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
P70 Telaprevir in combination with peginterferon and ribavirin in genotype 1 HCV Treatment-Naïve patients: final results of phase 3 ADVANCE StudyDusheiko, G M ; Bengtsson, L ; Adda, N ; Kauffman, R ; Jacobson, I MGut, 2011-09, Vol.60 (Suppl 2), p.A32-A33 [Periódico revisado por pares]London: BMJ Publishing Group Ltd and British Society of GastroenterologyTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Resistance to lamivudine therapy: is there more than meets the eye?Dusheiko, G ; Bertoletti, AGut, 2005-01, Vol.54 (1), p.9-10 [Periódico revisado por pares]England: BMJ Publishing Group Ltd and British Society of GastroenterologyTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
P48 Telaprevir substantially improved SVR rates across all IL28B genotypes in the advance trialDusheiko, G M ; Jacobson, I M ; Catlett, I ; George, S ; Seepersaud, S ; Ramachandran, R ; Sussky, K ; Kauffman, R S ; Botfield, MGut, 2011-09, Vol.60 (Suppl 2), p.A23-A23 [Periódico revisado por pares]London: BMJ Publishing Group Ltd and British Society of GastroenterologyTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
P17 Lusutrombopag reduces the need for platelet transfusion and lowers the risk of bleeding in patients with chronic liver disease prior to invasive procedures: a meta-analysisOrme, M ; Perard, R ; Bentley, R ; Marcella, S ; Agarwal, K ; Dusheiko, GGut, 2020-09, Vol.69 (Suppl 1), p.A15-A15 [Periódico revisado por pares]London: BMJ Publishing Group LTDTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Cytotoxic T lymphocyte responses and CTL epitope escape mutation in HBsAg, anti-HBe positive individualsKhakoo, S I ; Ling, R ; Scott, I ; Dodi, A I ; Harrison, T J ; Dusheiko, G M ; Madrigal, J AGut, 2000-07, Vol.47 (1), p.137-143 [Periódico revisado por pares]London: BMJ Publishing Group Ltd and British Society of GastroenterologyTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Longitudinal variation in hepatitis C virus (HCV) viraemia and early course of HCV infection after liver transplantation for HCV cirrhosis: the role of different immunosuppressive regimensPapatheodoridis, G V ; Barton, S G R G ; Andrew, D ; Clewley, G ; Davies, S ; Dhillon, A P ; Dusheiko, G ; Davidson, B ; Rolles, K ; Burroughs, A KGut, 1999-09, Vol.45 (3), p.427-434 [Periódico revisado por pares]London: BMJ Publishing Group Ltd and British Society of GastroenterologyTexto completo disponível |